A first case report of clinical response to targeted therapy in a patient with primary myoepithelial carcinoma of the lung harboring EGFR exon 19 deletion

BACKGROUND: Primary myoepithelial carcinoma of the lung is a rare subtype in lung cancer. Comprehensive molecular profiling of myoepithelial carcinoma of the lung is absent, neither was clinical evidence of targeted therapy available for this disease. Therefore, the optimal treatment regimen of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Xiaohong, Lin, Xinqing, Liu, Ming, Qin, Yinyin, Ouyang, Ming, Li, Shiyue, Gu, Yingying, Chen, Shuyin, Xiang, Jianxing, Zhou, Chengzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275596/
https://www.ncbi.nlm.nih.gov/pubmed/32505185
http://dx.doi.org/10.1186/s13000-020-00986-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275596/
https://www.ncbi.nlm.nih.gov/pubmed/32505185
http://dx.doi.org/10.1186/s13000-020-00986-0

Ejemplares similares